Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Tempst

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|July 18, 2013
Mass-encoded, synthetic biomarkers and multiplexed urinary monitoring: new frontiers in disease monitoringPaul Tempst
Nature|August 6, 2004
OvaCheck: let's not dismiss the conceptJosep Villanueva, Paul Tempst
Analytical Chemistry|December 4, 2003
Affinity capture of specific DNA-binding proteins for mass spectrometric identificationMariana Yaneva, Paul Tempst
Methods in Molecular Biology (Clifton, N.J.)|August 5, 2006
Isolation and mass spectrometry of specific DNA binding proteinsMariana Yaneva, Paul Tempst
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2002
Strategies for handling polypeptides on a micro-scaleBryan John Smith, Paul Tempst
Nature Methods|May 1, 2010
Super-SILAC for tumors and tissuesThomas A Neubert, Paul Tempst
Bioinformatics (Oxford, England)|April 17, 2004
PINdb: a database of nuclear protein complexes from human and yeastPhuong-Van Luc, Paul Tempst
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?Richard J Robbins, Josep Villanueva, Paul Tempst
Molecular Cell|April 22, 2004
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, et al.
Cancers|March 10, 2018
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and ChallengesAlex Root, Peter Allen, Paul Tempst, et al.
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|July 18, 2013
Mass-encoded, synthetic biomarkers and multiplexed urinary monitoring: new frontiers in disease monitoringPaul Tempst
Nature|August 6, 2004
OvaCheck: let's not dismiss the conceptJosep Villanueva, Paul Tempst
Analytical Chemistry|December 4, 2003
Affinity capture of specific DNA-binding proteins for mass spectrometric identificationMariana Yaneva, Paul Tempst
Methods in Molecular Biology (Clifton, N.J.)|August 5, 2006
Isolation and mass spectrometry of specific DNA binding proteinsMariana Yaneva, Paul Tempst
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2002
Strategies for handling polypeptides on a micro-scaleBryan John Smith, Paul Tempst
Nature Methods|May 1, 2010
Super-SILAC for tumors and tissuesThomas A Neubert, Paul Tempst
Bioinformatics (Oxford, England)|April 17, 2004
PINdb: a database of nuclear protein complexes from human and yeastPhuong-Van Luc, Paul Tempst
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?Richard J Robbins, Josep Villanueva, Paul Tempst
Molecular Cell|April 22, 2004
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, et al.
Cancers|March 10, 2018
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and ChallengesAlex Root, Peter Allen, Paul Tempst, et al.
Pageof 17